T1	Participants 21 74	docosahexaenoic acid in X-linked retinitis pigmentosa
T2	Participants 294 364	slow vision loss in patients with X-linked retinitis pigmentosa (XLRP)
T3	Participants 1871 1900	patients taking high dose DHA
